A 34 week preterm baby was admitted with the complaints of respiratory distress soon after birth. The mother had bad obstetric history. She is having the fifth gravida with the first two alive and healthy who were born by the normal vaginal delivery at home. The third child was born with severe jaundice and was treated by exchange transfusion. Subsequently the baby developed bilirubin encephalopathy. Then the baby developed cerebral palsy and ultimately died due to aspiration pneumonia at the age of 2.5 years.
Her first three pregnancies were not on any antenatal check-up by the health care provider due to poor socio-economic background and illiteracy. She enrolled herself under regular antenatal care at a local private hospital for the first time during the fourth pregnancy but it was ended with intrauterine death most probably due to Rh sensitization at 36 weeks of gestation at the hospital by lower segment cesarean section. The antibody titer was not done during the 4 th pregnancy but she took anti -D therapy after the delivery of dead fetus for the first time.
During this pregnancy, she was referred to the Bangabandhu Sheikh Mujib Medical University at her 10 th week of gestation as a high-risk pregnancy in view of better obstetric and neonatal outcome. She was also diagnosed as gestational diabetes mellitus at her 14 th weeks of gestation and was treated with insulin.
Thorough history, clinical examination and laboratory investigations were done during the admission into the fetomaternal unit. History and laboratory test revealed her blood group as B Rh negative and her husband's as B Rh positive. The antibody titer at 10 weeks of gestation was found above the critical value. The antibody titer was repeated accordingly and it showed rising pattern.
The fetal condition was closely monitored using ultrasonogram. So, the pregnancy was continuing in view of the absence of evidence of fetal hydrops on ultrasonogram. It was suspected as a case of pregnancy with Rh isoimmunisation. On the basis of raised antibody titer and bad obstetric history, she was counseled by neonatologist about the possible outcome of the current pregnancy and undergone emergency lower uterine cesarean section at 34 weeks of pregnancy after ensuring antenatal corticosteroid 7 days prior to delivery.
A male newborn weighing 2,800 g was born with the APGAR score 7 in the 1 st min and 9 in the 5 th min respectively, and the newborn was shifted for better and further management to the Neonatal Intensive Care Unit without any delay.
Soon after delivery, the baby developed respiratory distress requiring oxygen supplementation along with other standard newborn care. He was anemic but not edematous. No hepatosplenomegaly was found during the earlier examination. The blood samples were taken from the umbilical cord. The newborn's blood group was 'O' positive. The hemoglobin level was 8.7 g/dL. The total serum bilirubin level was 8.0 mg/dL. The direct antiglobulin test was positive. The peripheral smear showed anisopoikilocytosis of red cells with abundant polychromatic cells and relative lymphocytosis with eosinophilia.
In view of family history, critically raised antibody titer and highly suggestive cord blood report infant's blood was removed and replaced with fresh 'O' negative whole blood compatible with mother's serum at the age of 15 hours with all aseptic precaution. Both pre and post transfusion work up were done along with close clinical monitoring and single surface phototherapy. Single surface phototherapy was omitted at the age of 72 hours as serum bilirubin was declining and it was 7.8 mg/dL. Subsequently during neonatal course, baby developed twice episodes of rebound bilirubinemia which required treatment with phototherapy. The serum glycemic and electrolyte status of the baby were within the normal range throughout the neonatal course.
Follow-up hemoglobin and bilirubin level at the age of ninth postnatal age were 13.1 g/dL and 10.7 mg/dL respectively. The baby was discharged with stable condition, exclusive breast feeding on demand and advice for the follow-up. 
Provisional Diagnosis
Hemolytic disease of the neonate due to Rh isoimmunization
Differential Diagnosis
Dr. Shabnam: The history, clinical examination, antenatal workup and cord investigations were so obvious that no differential diagnosis could be made.
Shoyeb's Diagnosis
Discussion
Dr. Afshana Jahan: What is Rh isoimmunization and how does it happen?
Dr. Md. Nazmus Sihan: Rh isoimmunization is characterized by the formation of autoantibody if a woman of Rh negative blood group gets exposed to Rh positive blood. A difference in Rh type between an expectant mother and her baby, is a way when Rh isoimmunization can complicate the pregnancy.
The fetal blood, during pregnancy, can cross into the maternal bloodstream by feto-maternal hemorrhage. The primary immune response can be induced if the Rh negative blood gets exposed to even 1 mL of Rh positive red cells. 1, 2 Exposure of maternal Rh negative blood cells to the baby of Rh positive blood cells leads to the formation of antibodies against Rh negative blood cells. These antibodies can cross the placenta and attack the baby's red blood cells resulting in hemolytic anemia within the baby. This Rh isoimmunization usually does not cause any illness during the first pregnancy as the baby is born before antibody formation. But the condition is more likely to be serious in second or subsequent pregnancies (if the baby is Rh positive) as the Rh antibodies are there within the mother's body which was previously developed.
Dr. Tapash Chowdhury: Who is at risk of Rh isoimmunization?
Dr. Sihan: In case of inherited Rh factor, the baby has the 50% or more chance to have Rh positive blood group in case of Rh negative mother and Rh positive father. A Rh negative mother bearing an Rh positive fetus is prone to develop Rh isoimmunization.
The risk of Rh isoimmunization is higher if the Rh negative mother was exposed to Rh positive blood before the pregnancy. For instance, exposure during an earlier pregnancy (including the spontaneous and elective abortions), ectopic pregnancy, vaginal bleeding or amniotic discharge, previous invasive procedures (such as amniocentesis, cordocentesis, chorionic villous sampling) can result in the isoimmunization effect in the fetus or newborn. 1 The history of mismatched blood transfusion or the administration of Rh IgG can also increase the chance of isoimmunization. 1 Random blood sugar (mmol/L) 6.5
a g e P r ee x c h a n g e a t 1 5 . . .
P o s te x c h a n g e a t 1 6 . 5 . Dr. Sihan: Due to regular antenatal follow-up and routine administration of postnatal prophylactic anti-D immunoglobulin to all Rh negative mothers, the incidence of Rh-hemolytic disease of newborn has decreased dramatically in developed countries. 5, 6 According to recent data, anti-D positivity in women of reproductive age has been dropped down to as low as 2.6/1,000 samples. 5, 6 The trend of having nuclear families and improved perinatal care also contributed significantly towards this decline in morbidity and mortality from Rhhemolytic disease of a newborn. 7 However, several studies done in Bangladesh shows that there are high incidence of Rh isoimmunization due to large number of unbooked pregnancy and home delivery. It is about 5.4 to 15%. If the Rh incompatibility is known or suspected, then the serial Rh antibodies (at booking then at 20 weeks gestation, 24 and 28 weeks of gestation respectively) are advised during pregnancy.
The antibody level also can suggest the severity of hemolytic anemia in the fetus. Higher level or progressive rising of antibody titers are suggestive of more severe hemolytic anemia. 11 Presence of edema or the evidence of hydrops fetalis can be assessed by the routine ultrasonogram. Doppler ultrasound is even more useful to detect the blood flow through the artery and passive evidence of anemia. 11
Dr. Debabrata Roy: How can Rh isoimmunization be prevented?
Dr. Mohammad Kamrul Hassan Shabuj:
The Rh incompatibility can be prevented by administering anti-D. Once the mother is sensitized and formed the Rh antibodies, then no medicine is required to prevent the condition.
A woman having Rh negative blood must administer anti-D during the pregnancy (28 weeks gestation) and after each pregnancy (72 hours after delivery) or after any other event (abortion, miscarriage, ectopic pregnancy, amniocentesis, chorionic villus sampling) that may expose her Rh negative blood cells to Rh positive blood cells. 11 By routine antenatal care one can reduce or prevent the events linked to Rh isoimmunization by serial antibody estimation and ultrasonography.
Fetal RH D genotype can be determined by the presence of cell free DNA in the maternal plasma. Recent study suggests that the prediction of fetal D blood group along with the targeted antenatal anti-D prophylaxis is the optimal antenatal management. 12 Dr. Suman Sarkar: What to do if the antenatal titer is found to be high and the fetus has developed the signs of hemolytic anemia such as hydrops fetalis? 
